Generate Biomedicines is trading 5.28% down at $12.37, alongside weakness in biotech and broader risk-sensitive markets. - XBI is down 2.06%, while the Nasdaq is down 1.36%. - No clear company-specific catalyst for the October 16 move was identified. - The Zealand Pharma collaboration was announced October 13, with no reporting tying it to this decline.